AstraZeneca, Handa, Par get US antitrust claims trimmed in Seroquel XR case
MLex Summary: Plaintiffs’ claims accusing AstraZeneca of entering into an illegal reverse payment agreement with Accord Healthcare over the drug Seroquel XR are overly conclusory, a US federal judge ruled. District...To view the full article, register now.
Already a subscriber? Click here to view full article